Hints and tips:
Related Special Reports
...He rolls up his sleeves,” said Karen Massey, chief commercial officer at biotech company Argenx, who worked with him at Roche....
...The company is aiming to develop a wide range of drugs and use its manufacturing scale to stay ahead of pharmaceutical rivals seeking to profit from consumer “hype” for weight loss products, he added....
...AstraZeneca has acquired oncology biotech Fusion Pharmaceuticals for $2.4bn to build its expertise and challenge Swiss company Novartis in the developing field of a more targeted form of radiotherapy....
...It needs further deals to replenish its pharmaceuticals pipeline....
...But after years of trying, the pharmaceuticals industry is getting to grips with the multibillion-dollar problem of fatty liver disease....
...“The company’s main biological asset are NHPs used for pre-clinical trials....
...Novo Nordisk purchased Dicerna Pharmaceuticals, a company focused in RNA-based therapeutics, for $3.3bn in 2021....
...make up the backbone of pharmaceutical care....
...The deal will give the Danish pharmaceutical company a treatment for heart failure currently in mid-stage, phase 2 trials that targets root causes of heart disease....
...The company has warned of zero free cash flow for 2023....
...Pharmaceutical companies also have a key role to play in providing affordable access to these essential products. The global industry’s response to date has been inadequate and fragmented....
...Ireland’s GDP data, however, come with a caveat: the numbers are regularly skewed by the impact of global companies....
...Avid Bioservices, a small-cap company that helps develop and manufacture drugs for pharmaceutical companies, filed this with the SEC yesterday: On February 29, 2024, Avid Bioservices, Inc....
...The US pharmaceutical company — whose shares are up 130 per cent over the past year and is now a top-10 S&P 500 stock — chose the week of the Oscars to launch an advert called “Big Night”....
...The company said the decision was partly driven by huge demand for weight-loss drugs....
...For that reason, the 2023 FT Person of the Year went to Lars Fruergaard Jørgensen, chief executive of Novo Nordisk, the pharmaceutical company that brought these successful weight-loss drugs to market....
...The country is home to the third-largest pharmaceutical market in the world. There is still room for growth in Japan’s $53bn dispensing pharmacy market....
...New technology — particularly the application of immunology — is transforming dermatology from a low-margin pharmaceutical backwater into a fast-growing, high-value market, said Francesco De Rubertis, executive...
...He said that the company’s “four challenges greatly limit our ability to choose our destiny: whether that be as a three-division company or in smaller parts”....
...Hannah Kuchler All pharmaceutical innovation takes a long time, but I think the foundation ownership did play a big role here, because it means that the company, even though it is publicly listed, is maybe...
...Beyond these price pressures, pharmaceutical companies have other reasons to worry about their reliance on animal testing....
...The Association of the British Pharmaceutical Industry, the drugmakers’ trade body, said it supported “this tough deal” even though the agreement would continue to restrict pharmaceutical companies’ sales...
...Dato-DXd, which has been developed with Japanese pharmaceutical company Daiichi Sankyo, and Enhertu, another AstraZeneca treatment, are considered by analysts to be potentially high-earning drugs....
...This would result in FDA action being delayed beyond the first quarter, the company said in its statement....
...The US market is the engine of the global pharmaceutical industry. Its exceptionally high drug prices help deliver as much as three-quarters of the sector’s global profits....
International Edition